Food and Drug Administration approvals in phase 3 Cancer clinical trials

BACKGROUND: Phase 3 oncologic randomized clinical trials (RCTs) can lead to Food and Drug Administration (FDA) approvals. In this study, we aim to identify trial-related factors associated with trials leading to subsequent FDA drug approvals. METHODS: We performed a database query through the Clinic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Abi Jaoude, Joseph, Kouzy, Ramez, Ghabach, Marc, Patel, Roshal, Pasalic, Dario, Ghossain, Elie, Miller, Austin B., Lin, Timothy A., Verma, Vivek, Fuller, C. David, Subbiah, Vivek, Minsky, Bruce D., Ludmir, Ethan B., Taniguchi, Cullen M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8196526/
https://ncbi.nlm.nih.gov/pubmed/34118915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08457-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados